Control and Accountability of Prescription Medications (Resolution 107-3-11)

May 26, 2011 10:10 AM Topics: Resolutions

Resolution No. 107-3-11
Title: Control and Accountability of Prescription Medications
Action: Pass

Whereas, state boards of pharmacy are aware that prescription medications, including controlled substances, that are diverted from licensed pharmacies contribute to drug abuse, including abuse by children, adolescents, and teens; and

Whereas, the diversion of prescription drugs compromises patient safety; and

Whereas, preventing and detecting diversion is an important responsibility of state boards; and

Whereas, state boards use different methods and include in state practice acts and regulations provisions to encourage pharmacists and pharmacies to proactively maintain the security of controlled drugs;

THEREFORE BE IT RESOLVED that NABP commission a task force of interested stakeholders to review existing state laws and regulations addressing the control and accountability of prescription drugs, the Report of the Task Force to Review and Recommend Revisions to the Controlled Substances Act, as well as relevant sections of the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy (Model Act) to identify potential language for incorporation into the Model Act that will reflect the responsibility of licensed pharmacies and pharmacists to maintain control over prescription medications and provide workable examples of controls and monitoring measures that pharmacies and pharmacists can utilize to prevent, detect, and investigate losses of prescription drugs.
 

(Resolution passed at the NABP 107th Annual Meeting, San Antonio, TX)